Published in Mol Biol Cell on October 03, 2003
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A (2006) 6.90
Aptamer mediated siRNA delivery. Nucleic Acids Res (2006) 2.77
Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA). J Med Chem (2008) 2.03
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer. EMBO J (2006) 1.55
Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proc Natl Acad Sci U S A (2005) 1.49
Overview of prostate-specific membrane antigen. Rev Urol (2004) 1.34
Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer. Curr Med Chem (2012) 1.34
PSMA as a target for radiolabelled small molecules. Eur J Nucl Med Mol Imaging (2013) 1.33
Current use of PSMA-PET in prostate cancer management. Nat Rev Urol (2016) 1.27
Prostate-specific membrane antigen-based imaging. Urol Oncol (2012) 1.22
Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA). Cancer Biol Ther (2008) 1.18
Targeting 4-1BB costimulation to disseminated tumor lesions with bi-specific oligonucleotide aptamers. Mol Ther (2011) 1.17
Biorecognition and subcellular trafficking of HPMA copolymer-anti-PSMA antibody conjugates by prostate cancer cells. Mol Pharm (2009) 0.95
In vitro targeted photodynamic therapy with a pyropheophorbide--a conjugated inhibitor of prostate-specific membrane antigen. Prostate (2009) 0.93
Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternatives. Mol Pharm (2014) 0.91
Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability. Mol Cancer Ther (2008) 0.88
Alternative splicing within the I-II loop controls surface expression of T-type Ca(v)3.1 calcium channels. FEBS Lett (2008) 0.87
Molecular evolution of the transferrin receptor/glutamate carboxypeptidase II family. J Mol Evol (2006) 0.86
Biphasic (68)Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma. Eur J Nucl Med Mol Imaging (2015) 0.85
Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endothelial cells and its clinical significance. PLoS One (2015) 0.85
Evaluation of prostate-specific membrane antigen as an imaging reporter. J Nucl Med (2014) 0.80
Tomoregulin internalization confers selective cytotoxicity of immunotoxins on prostate cancer cells. Transl Oncol (2008) 0.79
Discriminatory Role of Detergent-Resistant Membranes in the Dimerization and Endocytosis of Prostate-Specific Membrane Antigen. PLoS One (2013) 0.79
Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells. Int J Oncol (2014) 0.78
The Utility of Molecular Imaging in Prostate Cancer. Curr Urol Rep (2016) 0.78
Synthesis and positron emission tomography evaluation of (18)F-Glu-Urea-Lys, a prostate-specific membrane antigen-based imaging agent for prostate cancer. Oncol Lett (2015) 0.78
Cancer stratification by molecular imaging. Int J Mol Sci (2015) 0.78
In Vivo Molecular MRI Imaging of Prostate Cancer by Targeting PSMA with Polypeptide-Labeled Superparamagnetic Iron Oxide Nanoparticles. Int J Mol Sci (2015) 0.78
Development of targeted near-infrared imaging agents for prostate cancer. Mol Cancer Ther (2014) 0.78
Synthesis and pre-clinical evaluation of a new class of high-affinity (18)F-labeled PSMA ligands for detection of prostate cancer by PET imaging. Eur J Nucl Med Mol Imaging (2016) 0.78
A multivalent approach of imaging probe design to overcome an endogenous anion binding competition for noninvasive assessment of prostate specific membrane antigen. Mol Pharm (2013) 0.77
The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease. Br J Pharmacol (2016) 0.76
PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer. Sci Signal (2017) 0.75
68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients. Oncotarget (2017) 0.75
In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe. Sci Rep (2016) 0.75
A novel cytoplasmic tail motif regulates mouse corin expression on the cell surface. Biochem Biophys Res Commun (2015) 0.75
68Ga-PSMA PET/CT imaging in recurrent prostate cancer: Where are we now? Cent European J Urol (2017) 0.75
Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem (2003) 13.66
Endocytosis and molecular sorting. Annu Rev Cell Dev Biol (1996) 8.83
Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science (1995) 7.77
Mutations in human dynamin block an intermediate stage in coated vesicle formation. J Cell Biol (1993) 7.37
Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature (1984) 7.37
Endocytosis. Physiol Rev (1997) 7.33
Signal-dependent membrane protein trafficking in the endocytic pathway. Annu Rev Cell Biol (1993) 7.16
Effects of mutant rat dynamin on endocytosis. J Cell Biol (1993) 5.05
A structural explanation for the recognition of tyrosine-based endocytotic signals. Science (1998) 5.03
A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell (1992) 4.39
Transcending the impenetrable: how proteins come to terms with membranes. Biochim Biophys Acta (1988) 4.08
Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res (1997) 4.05
Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res (1999) 3.58
Receptor-mediated endocytosis of hormones in cultured cells. Annu Rev Physiol (1981) 3.56
Adaptors for clathrin-mediated traffic. Annu Rev Cell Dev Biol (1999) 3.47
Linking cargo to vesicle formation: receptor tail interactions with coat proteins. Curr Opin Cell Biol (1997) 3.44
Molecular bases for the recognition of tyrosine-based sorting signals. J Cell Biol (1999) 3.29
A single amino acid change in the cytoplasmic domain allows the influenza virus hemagglutinin to be endocytosed through coated pits. Cell (1988) 3.26
Clathrin and adaptors. Biochim Biophys Acta (1998) 2.97
Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology (1996) 2.77
Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res (1997) 2.72
Inhibition of the receptor-binding function of clathrin adaptor protein AP-2 by dominant-negative mutant mu2 subunit and its effects on endocytosis. EMBO J (1999) 2.60
Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res (1999) 2.55
Tumor therapy with targeted atomic nanogenerators. Science (2001) 2.48
Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem (1999) 2.47
Protein sorting by tyrosine-based signals: adapting to the Ys and wherefores. Trends Cell Biol (1997) 2.44
A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac. Hybridoma (1985) 2.41
Targeting of membrane proteins to endosomes and lysosomes. Trends Cell Biol (1994) 2.38
Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res (1998) 2.38
The cytoplasmic tail of the mannose 6-phosphate/insulin-like growth factor-II receptor has two signals for lysosomal enzyme sorting in the Golgi. J Cell Biol (1992) 2.32
Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res (1993) 2.22
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res (1988) 1.91
Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin Cancer Res (1996) 1.88
Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat Med (1999) 1.79
A role for acidic residues in di-leucine motif-based targeting to the endocytic pathway. J Biol Chem (1995) 1.78
Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci U S A (1996) 1.70
Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor. J Nucl Med (2003) 1.61
The tyrosine-based lysosomal targeting signal in lamp-1 mediates sorting into Golgi-derived clathrin-coated vesicles. EMBO J (1996) 1.58
The mu2 subunit of the clathrin adaptor AP-2 binds to FDNPVY and YppØ sorting signals at distinct sites. Traffic (2002) 1.27
The leucine-based sorting motifs in the cytoplasmic domain of the invariant chain are recognized by the clathrin adaptors AP1 and AP2 and their medium chains. J Biol Chem (1999) 1.26
Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity. Cancer Res (2003) 1.22
Distinct reading of different structural determinants modulates the dileucine-mediated transport steps of the lysosomal membrane protein LIMPII and the insulin-sensitive glucose transporter GLUT4. J Biol Chem (2000) 1.21
TGN38 recycles basolaterally in polarized Madin-Darby canine kidney cells. Mol Biol Cell (1994) 1.20
The nagging question of the function of N-acetylaspartylglutamate. Neurobiol Dis (1997) 1.13
A di-hydrophobic Leu-Val motif regulates the basolateral localization of CD44 in polarized Madin-Darby canine kidney epithelial cells. J Biol Chem (1996) 1.09
Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II. J Biol Chem (1998) 1.06
Structural insights into clathrin-mediated endocytosis. Curr Opin Cell Biol (2000) 1.01
Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase). J Pharmacol Exp Ther (1998) 1.01
Site-directed mutagenesis of predicted active site residues in glutamate carboxypeptidase II. Mol Pharmacol (1999) 0.98
Characterization of a di-leucine-based signal in the cytoplasmic tail of the nucleotide-pyrophosphatase NPP1 that mediates basolateral targeting but not endocytosis. Mol Biol Cell (2001) 0.98
Isoforms of the Lutheran/basal cell adhesion molecule glycoprotein are differentially delivered in polarized epithelial cells. Mapping of the basolateral sorting signal to a cytoplasmic di-leucine motif. J Biol Chem (1999) 0.97
Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11. Genomics (1995) 0.87
Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line. Prostate (2003) 0.85
Monoclonal antibodies: will they become an integral part of the evaluation and treatment of prostate cancer--focus on prostate-specific membrane antigen? Curr Opin Urol (1999) 0.81
Release of endogenous N-acetylaspartylglutamate (NAAG) and uptake of [3H]NAAG in guinea pig cerebellar slices. Brain Res (1989) 0.77
The Database of Interacting Proteins: 2004 update. Nucleic Acids Res (2004) 23.67
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med (2012) 5.92
Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res (2006) 5.90
Mesenchymal stem cell-mediated functional tooth regeneration in swine. PLoS One (2006) 3.91
Bicelle crystallization: a new method for crystallizing membrane proteins yields a monomeric bacteriorhodopsin structure. J Mol Biol (2002) 3.11
An architectural framework that may lie at the core of the postsynaptic density. Science (2006) 2.91
The many faces of SAM. Sci STKE (2005) 2.87
89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo. J Nucl Med (2010) 2.82
Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer. Cancer Discov (2012) 2.76
Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer. Cancer Res (2011) 2.69
Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody. Lab Chip (2009) 2.56
H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat Genet (2012) 2.47
Pivotal role of the glycine-rich TM3 helix in gating the MscS mechanosensitive channel. Nat Struct Mol Biol (2005) 2.38
Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer. J Clin Oncol (2004) 2.27
The evolution of transmembrane helix kinks and the structural diversity of G protein-coupled receptors. Proc Natl Acad Sci U S A (2004) 2.19
Side-chain contributions to membrane protein structure and stability. J Mol Biol (2004) 2.13
Modest stabilization by most hydrogen-bonded side-chain interactions in membrane proteins. Nature (2008) 2.03
Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors. J Clin Oncol (2007) 1.95
The hidden treasure in apical papilla: the potential role in pulp/dentin regeneration and bioroot engineering. J Endod (2008) 1.95
SAM domains: uniform structure, diversity of function. Trends Biochem Sci (2003) 1.94
Transmembrane glycine zippers: physiological and pathological roles in membrane proteins. Proc Natl Acad Sci U S A (2005) 1.90
Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen. Proc Natl Acad Sci U S A (2011) 1.87
Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device. PLoS One (2012) 1.86
Transmembrane domain helix packing stabilizes integrin alphaIIbbeta3 in the low affinity state. J Biol Chem (2004) 1.84
Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Virol (2010) 1.80
The SAM domain of polyhomeotic forms a helical polymer. Nat Struct Biol (2002) 1.73
Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor. J Nucl Med (2003) 1.61
Derepression by depolymerization; structural insights into the regulation of Yan by Mae. Cell (2004) 1.59
Probing membrane protein unfolding with pulse proteolysis. J Mol Biol (2010) 1.58
Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. ChemMedChem (2008) 1.57
Anti-prostate-specific membrane antigen-based radioimmunotherapy for prostate cancer. Cancer (2010) 1.57
The molecular basis of the Caskin1 and Mint1 interaction with CASK. J Mol Biol (2011) 1.56
Crystallization of bacteriorhodopsin from bicelle formulations at room temperature. Protein Sci (2005) 1.52
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer. Clin Cancer Res (2013) 1.51
Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction. Mol Cell Biol (2006) 1.48
Molecular pathway for cancer metastasis to bone. J Biol Chem (2003) 1.47
Vitamin C modulates TET1 function during somatic cell reprogramming. Nat Genet (2013) 1.45
Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function. J Biol Chem (2006) 1.44
Clinical trials of cancer therapies targeting prostate-specific membrane antigen. Rev Recent Clin Trials (2007) 1.43
A limited universe of membrane protein families and folds. Protein Sci (2006) 1.41
Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate. Bioconjug Chem (2011) 1.37
Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms. Urology (2007) 1.34
Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol Biol Cell (2004) 1.33
HotPatch: a statistical approach to finding biologically relevant features on protein surfaces. J Mol Biol (2007) 1.32
Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen. J Urol (2003) 1.31
Is prostate-specific membrane antigen a multifunctional protein? Am J Physiol Cell Physiol (2005) 1.31
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Hum Pathol (2009) 1.31
Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Lab Invest (2004) 1.30
The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med (Berl) (2011) 1.30
Methods for measuring the thermodynamic stability of membrane proteins. Methods Enzymol (2009) 1.29
Snorkeling preferences foster an amino acid composition bias in transmembrane helices. J Mol Biol (2004) 1.29
First Cu(II) diamondoid net with 2-fold interpenetrating frameworks. The role of anions in the construction of the supramolecular arrays. Inorg Chem (2002) 1.29
Post-translational modifications of integral membrane proteins resolved by top-down Fourier transform mass spectrometry with collisionally activated dissociation. Mol Cell Proteomics (2010) 1.28
Regulation of enzyme localization by polymerization: polymer formation by the SAM domain of diacylglycerol kinase delta1. Structure (2008) 1.28
Proline substitutions are not easily accommodated in a membrane protein. J Mol Biol (2004) 1.27
Structural organization of a Sex-comb-on-midleg/polyhomeotic copolymer. J Biol Chem (2005) 1.26
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems. Vaccine (2004) 1.25
Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy. Bioconjug Chem (2004) 1.24
Dishonorable discharge: the oncogenic roles of cleaved E-cadherin fragments. Cancer Res (2012) 1.22
Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity. Cancer Res (2003) 1.22
Repression of Na,K-ATPase beta1-subunit by the transcription factor snail in carcinoma. Mol Biol Cell (2003) 1.22
Molecular mechanisms underlying the analgesic property of intrathecal dexmedetomidine and its neurotoxicity evaluation: an in vivo and in vitro experimental study. PLoS One (2013) 1.21
Na-K-ATPase regulates tight junction permeability through occludin phosphorylation in pancreatic epithelial cells. Am J Physiol Gastrointest Liver Physiol (2006) 1.19
A simple method for modeling transmembrane helix oligomers. J Mol Biol (2003) 1.19
Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics. Cell Res (2011) 1.19
Genome sequence of Stenotrophomonas maltophilia RR-10, isolated as an endophyte from rice root. J Bacteriol (2012) 1.18
Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants. BMC Neurosci (2008) 1.17
Dramatic destabilization of transmembrane helix interactions by features of natural membrane environments. J Am Chem Soc (2011) 1.17
Mouse orthotopic models for bladder cancer research. BJU Int (2009) 1.17
The affinity of GXXXG motifs in transmembrane helix-helix interactions is modulated by long-range communication. J Biol Chem (2004) 1.16
Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. J Clin Invest (2014) 1.16
Shifting hydrogen bonds may produce flexible transmembrane helices. Proc Natl Acad Sci U S A (2012) 1.16
Method to measure strong protein-protein interactions in lipid bilayers using a steric trap. Proc Natl Acad Sci U S A (2010) 1.15
Prediction of myelotoxicity based on bone marrow radiation-absorbed dose: radioimmunotherapy studies using 90Y- and 177Lu-labeled J591 antibodies specific for prostate-specific membrane antigen. J Nucl Med (2005) 1.14
Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Mol Cancer Ther (2010) 1.13
Flip-flopping membrane proteins. Nat Struct Mol Biol (2006) 1.13
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer. Eur J Nucl Med Mol Imaging (2014) 1.10
Pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody specific for prostate-specific membrane antigen: prediction of 90Y-J591 radiation dosimetry based on 111In or 177Lu? J Nucl Med (2005) 1.10
Genetic selection system for improving recombinant membrane protein expression in E. coli. Protein Sci (2009) 1.10
A role for zinc in postsynaptic density asSAMbly and plasticity? Trends Biochem Sci (2006) 1.10
Analysis of the Na,K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer (2003) 1.10
Na,K-ATPase inhibition alters tight junction structure and permeability in human retinal pigment epithelial cells. Am J Physiol Cell Physiol (2003) 1.09
Structural imperatives impose diverse evolutionary constraints on helical membrane proteins. Proc Natl Acad Sci U S A (2009) 1.08
Radioimmunotherapy of prostate cancer using 90Y- and 177Lu-labeled J591 monoclonal antibodies: effect of multiple treatments on myelotoxicity. Clin Cancer Res (2005) 1.08
Crystallizing membrane proteins using lipidic bicelles. Methods (2011) 1.08
Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET. J Nucl Med (2011) 1.07
Genome sequence of the rice-pathogenic bacterium Acidovorax avenae subsp. avenae RS-1. J Bacteriol (2011) 1.07
Na,K-ATPase and epithelial tight junctions. Front Biosci (Landmark Ed) (2009) 1.07
Real-time ultrasound elastography: its potential role in assessment of breast lesions. Ultrasound Med Biol (2008) 1.07
Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. J Immunol (2002) 1.07
Similar energetic contributions of packing in the core of membrane and water-soluble proteins. J Am Chem Soc (2009) 1.06
The relationship between serum thyrotropin and components of metabolic syndrome. Endocr J (2010) 1.06
Membrane channel structure of Helicobacter pylori vacuolating toxin: role of multiple GXXXG motifs in cylindrical channels. Proc Natl Acad Sci U S A (2004) 1.06
Interactions of tight junctions with membrane channels and transporters. Biochim Biophys Acta (2007) 1.06